chronic constipation
Gastroenterology · 2007–2011
3decisions
3medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| prucalopride For the treatment of moderate to severe chronic constipation in adults who are intolerant to or are not adequately controlled with both bulk forming agents and… | Nov 2011 | Not recommended | no section in document |
| macrogol 3350 chronic constipation or faecal impaction not adequately controlled with first line interventions such as bulk-forming agents; patients with malignant… | Nov 2007 | Recommended with restriction | no section in document |
| macrogol 3350 plus electrolytes Extension of listing for chronic constipation or faecal impaction not adequately controlled with first-line interventions such as bulk-forming agents, and… | Nov 2007 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.